Bikash Chatterjee
President and Chief Science Officer, Pharmatech Associates

Bikash Chatterjee is President and Chief Science Officer of Pharmatech Associates, a Hayward, Calif.-based company that provides consulting and services to the regulated life science industry. Bikash has been involved in the biopharmaceutical, pharmaceutical, medical device, and diagnostics industry for over 30 years. His expertise includes site selection, project management, design, and validation of facilities for U.S. and European regulatory requirements. Bikash can be reached at bchatterjee@pharmatechassociates.com.

Recently passed U.S. laws, including the FDA Safety and Innovation Act (FDASIA) and the 21st Century Cures Act, have renewed the discussion on clarifying the...
President and Chief Science Officer, Pharmatech Associates
|
5.16.2018
9:49am
What to expect from the FDA’s Updated Guidance on Use of Electronic Records & Electronic Signatures in Clinical Investigations under Part 11.
President and Chief Science Officer, Pharmatech Associates
|
1.18.2018
3:40pm
As the deadline looms for drug master files, the FDA moves toward e-filing.
President and Chief Science Officer, Pharmatech Associates
|
5.2.2017
12:16pm
In the U.S. and Europe, the approach to ensuring drug quality has many more similarities than differences. But there's one key difference.
President and Chief Science Officer, Pharmatech Associates
|
2.23.2017
12:00pm
There are myriad challenges when bringing together the drug development and device development process.
President and Chief Science Officer, Pharmatech Associates
|
11.16.2016
1:36pm